GE HealthCare Technologies GEHC
NASDAQ GEHC
$74.58 -0.04 (-0.05%)
At close: Aug 20, 2026 · 10:27 AM UTC

GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026)

GE HealthCare Technologies' (GEHC) quarterly Net Income towards Common Stockholders came in at $574.0 million in Q2 2026, up 14.8% YoY from $500.0 million in Q2 2025, and up 39.66% on a QoQ basis from $411.0 million in Q1 2026.

GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

GE HealthCare Technologies (GEHC) has 5 years of Net Income towards Common Stockholders data on file, last reported at $574.0 million in Q2 2026.

  • Quarterly Net Income towards Common Stockholders rose 14.8% year-over-year to $574.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.1 billion (down 10.0% YoY) and the FY2025 annual result came in at $2.1 billion, up 4.57% from the prior year.
  • Net Income towards Common Stockholders climbed to $574.0 million in Q2 2026, from $411.0 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $721.0 million in Q4 2024 to a low of $189.0 million in Q1 2023.
  • A 5-year average of $468.4 million and a median of $467.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders tumbled 51.41% — and 2024, when it soared 97.88%.
  • Tracing GEHC's Net Income towards Common Stockholders over 5 years: stood at $554.0 million in 2022, then fell by 27.26% to $403.0 million in 2023, then jumped by 78.91% to $721.0 million in 2024, then decreased by 16.5% to $602.0 million in 2025, then slipped by 4.65% to $574.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $574.0 million (Q2 2026), $411.0 million (Q1 2026), and $602.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.54 Bn 193.94 Bn 7.27 Bn 928.00 Mn
2 Stryker 129.61 Bn 126.14 Bn 4.50 Bn 1.28 Bn
3 Medtronic 120.10 Bn 110.88 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 52.52 Bn 48.27 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.69 Bn 32.75 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.78 Bn 31.68 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 621.86 Mn
9 Steris 23.09 Bn 22.61 Bn 684.20 Mn 201.00 Mn
10 Zimmer Biomet Holdings 19.37 Bn 18.96 Bn 1.54 Bn 199.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 574.00 Mn
Mar 31, 2026 411.00 Mn
Dec 31, 2025 602.00 Mn
Sep 30, 2025 464.00 Mn
Jun 30, 2025 500.00 Mn
Mar 31, 2025 588.00 Mn
Dec 31, 2024 721.00 Mn
Sep 30, 2024 470.00 Mn
Jun 30, 2024 428.00 Mn
Mar 31, 2024 374.00 Mn
Dec 31, 2023 403.00 Mn
Sep 30, 2023 375.00 Mn
Jun 30, 2023 418.00 Mn
Mar 31, 2023 189.00 Mn
Dec 31, 2022 554.00 Mn
Sep 30, 2022 487.00 Mn
Jun 30, 2022 485.00 Mn
Mar 31, 2022 389.00 Mn